Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 436Neoplasms 375Prostatic Neoplasms 211Lung Neoplasms 195Colorectal Neoplasms 154Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Head and Neck Neoplasms 75Carcinoma, Non-Small-Cell Lung 75Brain Neoplasms 71Ovarian Neoplasms 65Carcinoma, Hepatocellular 54Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 44Hematologic Neoplasms 43Depression 41Glioma 38Melanoma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 35Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Coronary Artery Disease × 90 days × Clear all
NCT04726319 2026-05-06

FHAMe

University of Toronto

Phase NA Completed
627 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡